The acquisition agreement is set to expand Aegis’s toxicology portfolio, while HealthTrackRx expands its PCR infectious disease testing.
Aegis Sciences Corporation, a US healthcare testing laboratory based in Nashville, Tenn., announced in January, its acquisition of the HealthTrackRx Toxicology line of business. Terms of the transaction were not disclosed.
Aegis has provided science-driven drug testing and consulting services since 1990. The laboratory delivers evidence-based, clinically actionable information related to medication compliance, substance abuse, and drug-drug interactions through definitive testing of urine, oral fluid, or blood specimens.
Dr. Frank Basile, Aegis Sciences Corporation CEO staed:
“Clinicians need the diagnostic ability to detect the most relevant prescribed, illicit, and synthetic drugs that directly affect patient outcomes.”
“This acquisition provides the opportunity for Aegis to deliver the most comprehensive clinical toxicology testing available to more providers.”
HealthTrackRx, a leading polymerase chain reaction (RT-PCR)-based infectious disease laboratory, was founded with a focus on clinical toxicology testing. Recently, the company has transitioned its growth strategy to infectious disease testing and combating antimicrobial resistance.
Martin Price, HealthTrackRx CEO and chairman commented:
“As we aggressively expand our infection detection capabilities and deliver next-morning PCR results nationwide, toxicology has become a declining portion of our clinical testing portfolio.”
“We are grateful for the opportunity to serve our toxicology clients over the past decade and know they are in good hands with Aegis.”
Mike Ziegler, Chief Commercial Officer, Aegis Sciences, said
“Aegis’s health care testing services are designed uniquely for the specialties we serve. We look forward to helping more clinicians make better decisions for their patients through our innovative approach.”
Original Source – NASHVILLE, Tenn.–(BUSINESS WIRE) – January 17, 2023 – https://www.businesswire.com/news/home/20230117005131/en/Aegis-Sciences-Corporation-Acquires-HealthTrackRx%E2%80%99s-Toxicology-Business-Unit